ghk-cu peptide dosage for humans Dosage: A Doctor's Guide to Calculations, Mixing & Safety Part 2 of my favourite

Morbidelli L, Donnini S, Ziche M

For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety

The Leyden 2002 facial-cream trial reported skin density, thickness, fine lines, and laxity changes at 12 weeks

Visual indicators include color change (from blue to green, brown, or cloudy), visible particles or precipitation, and unusual film or residue

OBM Geriatrics 2018;2(3):009